Singer-songwriter and musician, Amy Grant understands first-hand that cardiovascular disease (CVD) remains the No. 1 cause of death for women.
Valneva sells Ixchiq priority voucher for $103m to fuel R&D – Pharmaceutical Technology
Share this article Valneva plans to use the funds from the priority review voucher sale to advance its research and development (R&D) efforts. Image Credit: